Pinnacle Financial Partners, Inc.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 2082866
ATLANTA, GA
Position in BMRN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,972,009
New position
Shares Held
34,909
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 98.26405797931766.ToString("F0")%
Shared 1.7359420206823455.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pinnacle Financial Partners, Inc. holds $41,348,368 across 16 Biotechnology names. BMRN ranks #8 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,226 | $8,585,176 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
85,881 | $5,550,489 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
20,180 | $5,212,897 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
202,282 | $4,725,307 | |
| 5 | RPRX |
Royalty Pharma plc
|
86,614 | $4,154,872 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
22,865 | $3,864,642 | |
| 7 | VSTM |
Verastem, Inc.
|
495,266 | $2,624,909 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
34,909 | $1,972,009 |
All Filings in BMRN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,972,009 | 34,909 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||